Oryzon Genomics S.A. (LON: 0RDB)
London
· Delayed Price · Currency is GBP · Price in EUR 1.432
-0.044 (-2.98%)
Jan 23, 2025, 12:53 PM BST
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of 80.78 million as of January 23, 2025. Its market cap has decreased by -19.78% in one year.
Market Cap
80.78M
Enterprise Value
87.52M
Revenue
11.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.43
Market Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has decreased from 88.97M to 80.78M, a decrease of -9.21%. That is a compound annual growth rate of -1.05%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.37B |
| GSK plc | 55.43B |
| Haleon | 33.25B |
| Smith & Nephew | 9.04B |
| ConvaTec Group | 4.92B |
| Hikma Pharmaceuticals | 4.68B |
| HUTCHMED (China) | 1.94B |
| Oxford Nanopore Technologies | 1.48B |